Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.